Central Line-associated Bloodstream Infection (CLABSI)

2

Review clinical trials related to Central Line-associated Bloodstream Infection (CLABSI). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Central Line-Associated Bloodstream Infection QI Project

This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: NYU Langone HealthUpdated: Aug 5, 2026Locations: 1
Eligibility criteria

Not hospice patient class [+1]

No active central line [+1]

Status: Recruiting

Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital

* Review key history and clinical examination findings of cases with CLABSI. * Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI. * Determine antibiotic biogram of each organism isolated * Determine the prevalence of occurrence of Primary or secondary Blood stream infection, causing microorganism, and predisposing factors.

Participants needed: 600
Trial details
Age: 1+Biological sex: AllType: ObservationalSponsor: Port Said UniversityUpdated: Jun 13, 2024Locations: 2
Eligibility criteria

• Patients diagnosed with sepsis based on medical history, lab investigations an... [+1]

Patients diagnosed with sepsis proved by medical history, lab investigations and... [+1]